Island Pharmaceuticals has completed subject dosing for the phase 2b therapeutic arm of its phase 2a/b PROTECT clinical trial of ...

A study funded by the National Institutes of Health (NIH) has found that adults who were hospitalized for a severe infection, such as respiratory...

In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from clinical trials showing that...

University of Virginia Brain Institute and School of Medicine researchers have received an initial $9.3 million award from the National Institutes of...

The Department of Health (DOH) has ordered all government hospitals to ensure that their dengue fast lanes are functioning, as cases of the...

By Kalinga Seneviratne Since President Donald Trump made the shock announcement last week of  freezing United States’ (US) foreign aid budget...

A new study suggests that a combination of radiation therapy and immune checkpoint inhibitors (ICIs) may offer a less invasive alternative to bladder...

Introduction A groundbreaking advancement in medical science has been achieved as the world’s first artificial kidney has successfully undergone...

A phase 2 non-randomised clinical trial has demonstrated the potential benefits of pembrolizumab in patients with advanced clear cell gynaecological...

by Jennifer Shutt and Shauneen Miranda, Ohio Capital Journal February 21, 2025 WASHINGTON — A federal judge announced Friday she will extend a...